China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of the effects of statins and PCSK9 inhibitors on bone metabolism in patients with type 2 diabetes: a prospective, open-label, randomized controlled study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130942
Registration Time: 2026/08/26
Type: Interventional study
Primary Sponsor: Shanghai Yangpu District Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340134
Published by HT Digital Content Services with permission from Health Daily Digest....